National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

motexafin lutetium
A pentadentate aromatic metallotexaphyrin with photosensitizing properties. Motexafin lutetium preferentially accumulates in tumor cells due to their increased rates of metabolism and absorbs light, forming an extended high energy conformational state that produces high quantum yields of singlet oxygen, resulting in local cytotoxic effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:lutetium texaphrin
lutetium texaphyrin
US brand names:Antrin
Lutex
Lutrin
Code name:PCI-0123



Previous:MOPP regimen, Morinda citrifolia fruit extract, morphine sulfate, motesanib diphosphate, motexafin gadolinium
Next:Motrin, mouse gp100 plasmid DNA vaccine, mouse prostate-specific membrane antigen plasmid DNA vaccine, MOv-gamma chimeric receptor gene, Movalis

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov